Maravai LifeSciences’ (MRVI) business, TriLink BioTechnologies, recently partnered with Johns Hopkins University to significantly enhance research in RNA therapeutics. This collaboration aims to accelerate therapeutic development through a new center within the Johns Hopkins Whiting School of Engineering, leveraging TriLink’s cutting-edge RNA synthesis technology.Financial terms of the deal were not revealed.Investment and Technological ContributionTriLink BioTechnologies works as a best-in-class contract d ...